当前位置: X-MOL 学术Brain Dev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Schuurs‐Hoeijmakers syndrome: Severe expression of the recurrent PACS1 c.607C>T mutation
Brain and Development ( IF 1.4 ) Pub Date : 2021-05-14 , DOI: 10.1016/j.braindev.2021.04.006
Simone Gana 1 , Federica Morelli 2 , Massimo Plumari 1 , Anna Pichiecchio 3 , Sabrina Signorini 4 , Enza Maria Valente 5
Affiliation  

Background

Heterozygous mutations in the PACS1 gene have been shown to cause Schuurs-Hoeijmakers syndrome, a rare condition characterized by intellectual disability and peculiar facial dysmorphisms. To date, 52 cases have been reported (49 postnatally and 3 prenatally diagnosed). Case report: We describe a child carrying the recurrent PACS1 c.607C>A variant; besides the typical neurodevelopmental and physical features of the condition, he also showed previously unreported cerebellar and ocular findings.

Conclusions

Our findings expand the clinical and neuroimaging presentation of Schuurs-Hoeijmakers syndrome and confirm the power of “genotype first” approach in patients with syndromic phenotypes. We also suggest a role for PACS1 in influencing cerebellar and ocular development.



中文翻译:


Schuurs-Hoeijmakers 综合征:复发性 PACS1 c.607C>T 突变的严重表达


 背景


PACS1基因的杂合突变已被证明会导致 Schuurs-Hoeijmakers 综合征,这是一种以智力障碍和特殊面部畸形为特征的罕见疾病。迄今为止,已报告 52 例病例(49 例产后诊断,3 例产前诊断)。病例报告:我们描述了一名携带复发性PACS1 c.607C>A 变异的儿童;除了该病的典型神经发育和身体特征外,他还表现出以前未报道的小脑和眼部发现。

 结论


我们的研究结果扩展了 Schuurs-Hoeijmakers 综合征的临床和神经影像学表现,并证实了“基因型优先”方法对综合征表型患者的功效。我们还提出了PACS1在影响小脑和眼部发育中的作用。

更新日期:2021-05-14
down
wechat
bug